Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Studies on the metabolic fate of (/sup 14/C)2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouse

Journal Article · · Toxicol. Appl. Pharmacol.; (United States)
After a single po dose (135 micrograms/kg; 62 microCi/kg) of /sup 14/C-labeled 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in male ICR/Ha Swiss mice, 67 to 76% of the administered dose was eliminated via the feces and 1 to 2% in the urine during the first 24 hr following treatment. It seems likely that most of this material was simply not absorbed. Much of the remaining chemical was then excreted slowly in the urine (2%) and feces (7%) during the next 10 days, partly as the unchanged compound and partly as metabolites. One of the metabolites (Fraction II) appears to be a single polar, acidic metabolite characterized in urine (0.4 +/- 0.1%) and feces (2.2 +/- 0.2%), and is also likely excreted as a glucuronide conjugate. The rest of the radioactivity was in the form of unchanged TCDD in the animal body (17 +/- 2%). Steady rates of decline in the concentrations of the /sup 14/C as well as of the unchanged TCDD were reached in the feces and urine after the fifth day following the administration of the chemical. Based on this steady rate, the half-life of the radioactivity in the body was approximately 20 days. Urine, feces, and whole body were analyzed by solvent extraction, /sup 14/C counting, thin-layer chromatography, and countercurrent distribution.
Research Organization:
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee
OSTI ID:
7007970
Journal Information:
Toxicol. Appl. Pharmacol.; (United States), Journal Name: Toxicol. Appl. Pharmacol.; (United States) Vol. 73:1; ISSN TXAPA
Country of Publication:
United States
Language:
English